| Benjamin Stewart Huneycutt, MD | |
|
Peacehealth Hospital Medicine, 3377 Riverbend Drive, Springfield, OR 97477-8803 | |
| (541) 222-6389 | |
| (541) 222-6385 |
| Full Name | Benjamin Stewart Huneycutt |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 29 Years |
| Location | Peacehealth Hospital Medicine, Springfield, Oregon |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023050549 | NPI | - | NPPES |
| 64069305 | Medicaid | KY | |
| 0111228 | Medicaid | OH | |
| P00479644 | Other | KY | MEDICARE RAILROAD |
| 500812735 | Medicaid | OR |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sacred Heart Medical Center - Riverbend | Springfield, OR | Hospital |
| Presbyterian Santa Fe Medical Center | Santa fe, NM | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hospitalist Medicine Physicians Of Texas Pllc | 3476688318 | 951 |
| Peacehealth | 8527016039 | 174 |
News Archive
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), announced today that it has entered into a research collaboration with Mirna Therapeutics (Austin, TX), to determine the utility of combining RXi's proprietary rxRNA™ technology with Mirna's microRNA mimics as potential therapeutics in oncology. The parties will each contribute technology and resources to the collaboration to generate and evaluate novel microRNA compounds.
The Monell Center and Jefferson (Philadelphia University and Thomas Jefferson University) announced today the signing of an Agreement of Cooperation, outlining how the two institutions will collaborate over the next year to develop joint scientific programs and clinical opportunities to advance their shared mission of improving human health.
Occupational settings can involve exposure to loud noise, a known and preventable contributor to hearing loss.
Researchers from Brigham and Women's Hospital led by Ying Bao, MD, ScD, an epidemiologist in BWH's Channing Division of Network Medicine and Assistant Professor at Harvard Medical School, have found that women with stronger social networks had better survival after colorectal cancer diagnosis and conclude that social network strengthening could be a tool for management of colorectal cancer.
› Verified 3 days ago
| Entity Name | Presbyterian Healthcare Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104802354 PECOS PAC ID: 9234041708 Enrollment ID: O20031103000603 |
News Archive
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), announced today that it has entered into a research collaboration with Mirna Therapeutics (Austin, TX), to determine the utility of combining RXi's proprietary rxRNA™ technology with Mirna's microRNA mimics as potential therapeutics in oncology. The parties will each contribute technology and resources to the collaboration to generate and evaluate novel microRNA compounds.
The Monell Center and Jefferson (Philadelphia University and Thomas Jefferson University) announced today the signing of an Agreement of Cooperation, outlining how the two institutions will collaborate over the next year to develop joint scientific programs and clinical opportunities to advance their shared mission of improving human health.
Occupational settings can involve exposure to loud noise, a known and preventable contributor to hearing loss.
Researchers from Brigham and Women's Hospital led by Ying Bao, MD, ScD, an epidemiologist in BWH's Channing Division of Network Medicine and Assistant Professor at Harvard Medical School, have found that women with stronger social networks had better survival after colorectal cancer diagnosis and conclude that social network strengthening could be a tool for management of colorectal cancer.
› Verified 3 days ago
| Entity Name | Rehoboth Mckinley Christian Health Care Services, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720084999 PECOS PAC ID: 1759293855 Enrollment ID: O20031105000466 |
News Archive
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), announced today that it has entered into a research collaboration with Mirna Therapeutics (Austin, TX), to determine the utility of combining RXi's proprietary rxRNA™ technology with Mirna's microRNA mimics as potential therapeutics in oncology. The parties will each contribute technology and resources to the collaboration to generate and evaluate novel microRNA compounds.
The Monell Center and Jefferson (Philadelphia University and Thomas Jefferson University) announced today the signing of an Agreement of Cooperation, outlining how the two institutions will collaborate over the next year to develop joint scientific programs and clinical opportunities to advance their shared mission of improving human health.
Occupational settings can involve exposure to loud noise, a known and preventable contributor to hearing loss.
Researchers from Brigham and Women's Hospital led by Ying Bao, MD, ScD, an epidemiologist in BWH's Channing Division of Network Medicine and Assistant Professor at Harvard Medical School, have found that women with stronger social networks had better survival after colorectal cancer diagnosis and conclude that social network strengthening could be a tool for management of colorectal cancer.
› Verified 3 days ago
| Entity Name | Artesia General Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114076825 PECOS PAC ID: 9537070586 Enrollment ID: O20031111000413 |
News Archive
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), announced today that it has entered into a research collaboration with Mirna Therapeutics (Austin, TX), to determine the utility of combining RXi's proprietary rxRNA™ technology with Mirna's microRNA mimics as potential therapeutics in oncology. The parties will each contribute technology and resources to the collaboration to generate and evaluate novel microRNA compounds.
The Monell Center and Jefferson (Philadelphia University and Thomas Jefferson University) announced today the signing of an Agreement of Cooperation, outlining how the two institutions will collaborate over the next year to develop joint scientific programs and clinical opportunities to advance their shared mission of improving human health.
Occupational settings can involve exposure to loud noise, a known and preventable contributor to hearing loss.
Researchers from Brigham and Women's Hospital led by Ying Bao, MD, ScD, an epidemiologist in BWH's Channing Division of Network Medicine and Assistant Professor at Harvard Medical School, have found that women with stronger social networks had better survival after colorectal cancer diagnosis and conclude that social network strengthening could be a tool for management of colorectal cancer.
› Verified 3 days ago
| Entity Name | Hospitalist Medicine Physicians Of Texas Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629307095 PECOS PAC ID: 3476688318 Enrollment ID: O20151019001400 |
News Archive
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), announced today that it has entered into a research collaboration with Mirna Therapeutics (Austin, TX), to determine the utility of combining RXi's proprietary rxRNA™ technology with Mirna's microRNA mimics as potential therapeutics in oncology. The parties will each contribute technology and resources to the collaboration to generate and evaluate novel microRNA compounds.
The Monell Center and Jefferson (Philadelphia University and Thomas Jefferson University) announced today the signing of an Agreement of Cooperation, outlining how the two institutions will collaborate over the next year to develop joint scientific programs and clinical opportunities to advance their shared mission of improving human health.
Occupational settings can involve exposure to loud noise, a known and preventable contributor to hearing loss.
Researchers from Brigham and Women's Hospital led by Ying Bao, MD, ScD, an epidemiologist in BWH's Channing Division of Network Medicine and Assistant Professor at Harvard Medical School, have found that women with stronger social networks had better survival after colorectal cancer diagnosis and conclude that social network strengthening could be a tool for management of colorectal cancer.
› Verified 3 days ago
| Entity Name | Island Medical Hospitalist Carlsbad Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144697129 PECOS PAC ID: 8325358039 Enrollment ID: O20151110000340 |
News Archive
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), announced today that it has entered into a research collaboration with Mirna Therapeutics (Austin, TX), to determine the utility of combining RXi's proprietary rxRNA™ technology with Mirna's microRNA mimics as potential therapeutics in oncology. The parties will each contribute technology and resources to the collaboration to generate and evaluate novel microRNA compounds.
The Monell Center and Jefferson (Philadelphia University and Thomas Jefferson University) announced today the signing of an Agreement of Cooperation, outlining how the two institutions will collaborate over the next year to develop joint scientific programs and clinical opportunities to advance their shared mission of improving human health.
Occupational settings can involve exposure to loud noise, a known and preventable contributor to hearing loss.
Researchers from Brigham and Women's Hospital led by Ying Bao, MD, ScD, an epidemiologist in BWH's Channing Division of Network Medicine and Assistant Professor at Harvard Medical School, have found that women with stronger social networks had better survival after colorectal cancer diagnosis and conclude that social network strengthening could be a tool for management of colorectal cancer.
› Verified 3 days ago
| Entity Name | Island Medical Hospitalist Lea Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215307194 PECOS PAC ID: 8527368943 Enrollment ID: O20151207002531 |
News Archive
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), announced today that it has entered into a research collaboration with Mirna Therapeutics (Austin, TX), to determine the utility of combining RXi's proprietary rxRNA™ technology with Mirna's microRNA mimics as potential therapeutics in oncology. The parties will each contribute technology and resources to the collaboration to generate and evaluate novel microRNA compounds.
The Monell Center and Jefferson (Philadelphia University and Thomas Jefferson University) announced today the signing of an Agreement of Cooperation, outlining how the two institutions will collaborate over the next year to develop joint scientific programs and clinical opportunities to advance their shared mission of improving human health.
Occupational settings can involve exposure to loud noise, a known and preventable contributor to hearing loss.
Researchers from Brigham and Women's Hospital led by Ying Bao, MD, ScD, an epidemiologist in BWH's Channing Division of Network Medicine and Assistant Professor at Harvard Medical School, have found that women with stronger social networks had better survival after colorectal cancer diagnosis and conclude that social network strengthening could be a tool for management of colorectal cancer.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Benjamin Stewart Huneycutt, MD Peacehealth Hospital Medicine, 3377 Riverbend Drive, Springfield, OR 97477-8803 Ph: (541) 222-6389 | Benjamin Stewart Huneycutt, MD Peacehealth Hospital Medicine, 3377 Riverbend Drive, Springfield, OR 97477-8803 Ph: (541) 222-6389 |
News Archive
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), announced today that it has entered into a research collaboration with Mirna Therapeutics (Austin, TX), to determine the utility of combining RXi's proprietary rxRNA™ technology with Mirna's microRNA mimics as potential therapeutics in oncology. The parties will each contribute technology and resources to the collaboration to generate and evaluate novel microRNA compounds.
The Monell Center and Jefferson (Philadelphia University and Thomas Jefferson University) announced today the signing of an Agreement of Cooperation, outlining how the two institutions will collaborate over the next year to develop joint scientific programs and clinical opportunities to advance their shared mission of improving human health.
Occupational settings can involve exposure to loud noise, a known and preventable contributor to hearing loss.
Researchers from Brigham and Women's Hospital led by Ying Bao, MD, ScD, an epidemiologist in BWH's Channing Division of Network Medicine and Assistant Professor at Harvard Medical School, have found that women with stronger social networks had better survival after colorectal cancer diagnosis and conclude that social network strengthening could be a tool for management of colorectal cancer.
› Verified 3 days ago
Cristian Mugurel Hutanu, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: Peacehealth Hospital Medicine, 3377 River Bend Drive, Springfield, OR 97477 Phone: 541-222-6389 Fax: 541-222-6385 | |
Kantee Karki, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 3333 Riverbend Dr, Springfield, OR 97477 Phone: 541-222-6389 | |
Basanta Pathak, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: Peacehealth Hospital Medicine, 3377 Riverbend Drive, Springfield, OR 97477 Phone: 541-222-6389 Fax: 541-222-6385 | |
Dr. Marc Joseph Coz Zarraga, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 3333 Riverbend Dr, Springfield, OR 97477 Phone: 541-222-6389 Fax: 541-222-6385 | |
Zakhar Serkin, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 3377 Riverbend Dr, Springfield, OR 97477 Phone: 541-222-8400 Fax: 541-222-8401 | |
Dr. Joanna Marie Bautista Aquino-laban, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 3377 Riverbend Dr, Springfield, OR 97477 Phone: 541-222-6389 Fax: 541-222-6385 | |
Brittany Ellison, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: Peacehealth Hospital Medicine, 3377 Riverbend Drive, Springfield, OR 97477 Phone: 541-222-6389 Fax: 541-222-6385 |